Novel therapeutic strategy for breast cancer: mammalian target of rapamycin inhibition

Author： Yip Adrian Yun-San Ong Eleanor Yuen-Yuen Chow Louis Wing-Cheong

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.4, 2009-04, pp. : 457-466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mammalian target of rapamycin as a therapeutic target in oncology

By Abraham Robert T Eng Christina H

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 209-222

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the mammalian target of rapamycin

By Dancey Janet E

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 313-328

Informa Healthcare

Access to resources Recommend Favorite

Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer

By Nelson Valerie Altman Jessica K Platanias Leonidas C

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

New inhibitors of the mammalian target of rapamycin signaling pathway for cancer

By Albert Sébastien Serova Maria Dreyer Chantal Sablin Marie-Paule Faivre Sandrine Raymond Eric

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 919-930

Informa Healthcare

Access to resources Recommend Favorite

Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 621-635

Bentham Science Publishers

Access to resources Recommend Favorite